Georgeta Fried
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Pancreatic and Hepatic Oncology Research
- Cancer survivorship and care
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 24
- HER2/EGFR in Cancer Research 7
- Cancer survivorship and care 6
-
- Advanced Breast Cancer Therapies 9
- Cancer-related cognitive impairment studies 4
- Co-authors
- Bella Kaufman (10 shared papers)Ora Rosengarten (10 shared papers)Salomon M. Stemmer (9 shared papers)Judith Balmañà (4 shared papers)Susan M. Domchek (4 shared papers)Ronnie Shapira‐Frommer (4 shared papers)Michael Friedländer (4 shared papers)Gillian Mitchell (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Breast Cancer Research and Treatment (3 papers)Cancer Research (3 papers)SpringerPlus (2 papers)Annals of Oncology (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Georgeta Fried
37 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.6k
- Reproductive Medicine 432
- Cancer Research 539
- Genetics 502
- Pulmonary and Respiratory Medicine 364
Countries citing papers authored by Georgeta Fried
This map shows the geographic impact of Georgeta Fried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgeta Fried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgeta Fried more than expected).
Fields of papers citing papers by Georgeta Fried
This network shows the impact of papers produced by Georgeta Fried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgeta Fried. The network helps show where Georgeta Fried may publish in the future.
Co-authors
The 25 scholars most cited alongside Georgeta Fried, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation Hit paper breakdown → | 2014 | 1241 |
| 2 | 2015 | 218 | |
| 3 | 2017 | 68 | |
| 4 | 2007 | 68 | |
| 5 | 2018 | 53 | |
| 6 | 2018 | 36 | |
| 7 | 2014 | 31 | |
| 8 | 2016 | 29 | |
| 9 | 2014 | 26 | |
| 10 | 2020 | 26 | |
| 11 | 2019 | 23 | |
| 12 | 2013 | 23 | |
| 13 | 2013 | 23 | |
| 14 | 2016 | 22 | |
| 15 | 2020 | 20 | |
| 16 | 2000 | 19 | |
| 17 | 2014 | 18 | |
| 18 | 2015 | 15 | |
| 19 | 2016 | 15 | |
| 20 | 2017 | 12 |
About Georgeta Fried
Georgeta Fried is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 38 papers that have together received 2.1k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (12 papers), Breast Cancer Treatment Studies (11 papers), Advanced Breast Cancer Therapies (9 papers), HER2/EGFR in Cancer Research (7 papers), Cancer survivorship and care (6 papers), Cancer Genomics and Diagnostics (5 papers), Medical Imaging Techniques and Applications (4 papers) and Cancer-related cognitive impairment studies (4 papers). The work is most often cited by research in Oncology (1.6k citations), Reproductive Medicine (432 citations), Cancer Research (539 citations), Genetics (502 citations) and Pulmonary and Respiratory Medicine (364 citations). Georgeta Fried has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Bella Kaufman, Ora Rosengarten, Salomon M. Stemmer, Judith Balmañà, Susan M. Domchek, Ronnie Shapira‐Frommer, Michael Friedländer, Gillian Mitchell, M. William Audeh and Ayala Hubert. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, SpringerPlus and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.